Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2268962rdf:typepubmed:Citationlld:pubmed
pubmed-article:2268962lifeskim:mentionsumls-concept:C0013216lld:lifeskim
pubmed-article:2268962lifeskim:mentionsumls-concept:C0006118lld:lifeskim
pubmed-article:2268962lifeskim:mentionsumls-concept:C1561451lld:lifeskim
pubmed-article:2268962pubmed:issue6lld:pubmed
pubmed-article:2268962pubmed:dateCreated1991-2-21lld:pubmed
pubmed-article:2268962pubmed:abstractTextDirect comparisons of theoretical modeling with actual drug delivery can lead to improved brain tumor therapy. In this study, normal and brain tumor-bearing rabbits received infusions of BCNU, or carmustine (1,3-bis [2-chlorethyl]-1-nitrosourea), with ethanol or hyperoxygenated perfluorocarbons as BCNU diluent. When ethanol was used as a diluent, right (infused) hemisphere:left (noninfused) hemisphere ratios of BCNU concentrations in both rabbit groups were markedly lower than had been predicted with theoretical pharmacokinetic modeling. When perfluorocarbons were used as a diluent, ratios of BCNU were significantly improved. These laboratory studies were directly translated into a two-phase protocol for human brain tumor patients. This combined research program demonstrates the successful integration of laboratory and clinical programs.lld:pubmed
pubmed-article:2268962pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2268962pubmed:languageenglld:pubmed
pubmed-article:2268962pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2268962pubmed:citationSubsetIMlld:pubmed
pubmed-article:2268962pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2268962pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2268962pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2268962pubmed:statusMEDLINElld:pubmed
pubmed-article:2268962pubmed:monthSeplld:pubmed
pubmed-article:2268962pubmed:issn0891-1150lld:pubmed
pubmed-article:2268962pubmed:authorpubmed-author:AndersonJ HJHlld:pubmed
pubmed-article:2268962pubmed:authorpubmed-author:HassenbuschS...lld:pubmed
pubmed-article:2268962pubmed:authorpubmed-author:WhitingD MDMlld:pubmed
pubmed-article:2268962pubmed:issnTypePrintlld:pubmed
pubmed-article:2268962pubmed:volume57lld:pubmed
pubmed-article:2268962pubmed:ownerNLMlld:pubmed
pubmed-article:2268962pubmed:authorsCompleteYlld:pubmed
pubmed-article:2268962pubmed:pagination513-20lld:pubmed
pubmed-article:2268962pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:2268962pubmed:meshHeadingpubmed-meshheading:2268962-...lld:pubmed
pubmed-article:2268962pubmed:meshHeadingpubmed-meshheading:2268962-...lld:pubmed
pubmed-article:2268962pubmed:meshHeadingpubmed-meshheading:2268962-...lld:pubmed
pubmed-article:2268962pubmed:meshHeadingpubmed-meshheading:2268962-...lld:pubmed
pubmed-article:2268962pubmed:meshHeadingpubmed-meshheading:2268962-...lld:pubmed
pubmed-article:2268962pubmed:meshHeadingpubmed-meshheading:2268962-...lld:pubmed
pubmed-article:2268962pubmed:meshHeadingpubmed-meshheading:2268962-...lld:pubmed
pubmed-article:2268962pubmed:meshHeadingpubmed-meshheading:2268962-...lld:pubmed
pubmed-article:2268962pubmed:meshHeadingpubmed-meshheading:2268962-...lld:pubmed
pubmed-article:2268962pubmed:year1990lld:pubmed
pubmed-article:2268962pubmed:articleTitleIntra-arterial chemotherapy for brain tumors.lld:pubmed
pubmed-article:2268962pubmed:affiliationDepartment of Neurosurgery, Cleveland Clinic Foundation, Ohio 44195-5226.lld:pubmed
pubmed-article:2268962pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2268962pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:2268962pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:2268962pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed